v3.26.1
Shareholders’ Equity (Tables)
3 Months Ended
Mar. 31, 2026
Shareholders’ Equity [Abstract]  
Schedule of Outstanding Warrants Total outstanding warrants as of March 31, 2026, are as follow:
   Number of
warrants
   Exercise
price
   Period left
in years
 
Warrants May 2023   6,613   $46.25    1.2 
Warrants December 2023   8,899   $14.75    2.75 
Warrants June 2024   6,998   $34.375    3.6 
Warrants July 2024   6,998   $25    0.2 
Warrants July 2025   499,188   $ 6.2-$7.7    2.12 
Warrants September 2025   670,421   $ 3.7-$4.6    3.06 
Warrants October 2025   10,000   $3.7    4.4 
Warrants December 2025   6,687,500   $0.8-$1    4.75 
Other   3,679   $102.7 - $500    0.3 – 1.2 
Outstanding as of March 31, 2026   7,900,296           
Schedule of Share Options, Granted to Employees, Directors, Under Option Plans A summary of the Company’s share options, granted to employees, directors, under option plans is as follows:
   Number of
options
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual
Life
 
Outstanding – January 1, 2026   3,957   $36.3    1.3 
Granted   
-
    
-
    - 
Exercised   
-
    
-
    - 
Forfeited   (152)   (6.44)   - 
                
Outstanding – March 31, 2026   3,805    35    1 
Exercisable – March 31, 2026   3,721    34    1 
Schedule of RSUs, Granted to Employees, Directors, Under Option Plans A summary of the Company’s RSUs, granted to employees, directors, under option plans is as follows:
   March 31, 2026 
   Number of
RSUs
   Weighted-
Average
Grant
Date Fair
Value
 
RSUs outstanding at the beginning of the year   173,789    4.36 
Granted during the period   1,000    1.1 
Vested during the period   (2,165)   4.4 
Forfeited during the period   (1,568)   (2.63)
Outstanding as of March 31, 2026   171,208    4.36